Despite many years of research, no biomarkers for stroke are available to use in clinical
practice. Progress in high-throughput technologies has provided new opportunities to …

Biomarkers are objective indicators used to assess normal or pathological processes,
evaluate responses to treatment and predict outcomes. Many blood biomarkers already …

Background Despite successful recanalization after endovascular treatment, many patients
with acute ischemic stroke due to large vessel occlusion still show functional dependence …

Although recent technical advances in thrombectomy have revolutionised acute stroke
treatment, prevalence of disability and death related to stroke remain high. Therefore …

Acute stroke is associated with high morbidity and mortality. In the last decades, new
therapies have been investigated with the aim of improving clinical outcomes in the acute …

Background: We aimed to identify plasma markers of unfavorable outcomes for patients with
acute ischemic stroke (AIS) after recanalization by endovascular thrombectomy (EVT) …

The structure of stroke thrombi has gained an increasing amount of interest in recent years.
The advent of endovascular thrombectomy has offered the unique opportunity to provide …

During the last decade, significant progress has been made in understanding thrombus
composition and organization in the setting of acute ischemic stroke (AIS). In particular …

Objective To assess whether interleukin-6 (IL-6) level is a marker of futile reperfusion in
patients with acute ischemic stroke (AIS) with large vessel occlusion treated with mechanical …

Background Neuroinflammatory response contributes to early neurological deterioration
(END) and unfavorable long-term functional outcome in patients with acute ischemic stroke …